Form 4 for CRL Charles River Laboratories
Accepted 2022-06-01 00:00:00 ET · period of report 2022-03-11 · accession 0001127602-22-016208 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-01 | 2022-05-28+ | CRL | Barbo William D | CCO, Corp. Executive VP | F - Tax | $244.41 | -314 | 4,396 | -7% | -$76.7K |
| D | 2022-06-01 | 2022-05-27 | CRL | Barbo William D | CCO, Corp. Executive VP | A - Grant | $0.00 | +1,493 | 4,508 | +50% | $0 |
| D | 2022-06-01 | 2022-03-11 | CRL | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | -754 | 3,015 | -20% | $0 |
| DI | 2022-06-01 | 2022-03-11 | CRL | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | +754 | 18.8K | +4% | $0 |
| D | 2022-06-01 | 2022-05-27 | CRL | Barbo William D | CCO, Corp. Executive VP | A - Grant | $244.41 | +4,036 | 4,036 | New | +$986.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-29 | F | D | 202 | $244.41 | 4,194 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-28 | F | D | 112 | $244.41 | 4,396 | D | — | — | |
| 3 | Common | Common Stock | 2022-05-27 | A | A | 1,493 | $0.00 | 4,508 | D | — | — | (F1) Unvested restricted stock units vest as follows: 373 on May 27, 2023, 373 on May 27, 2024, 373 on May 27, 2025 and 374 on May 27, 2026. |
| 4 | Common | Common Stock | 2022-03-11 | G | D | 754 | $0.00 | 3,015 | D By Trust | — | — | |
| 5 | Common | Common Stock | 2022-03-11 | G | A | 754 | $0.00 | 18,844 | I | — | — | |
| 6 | Derivative | Stock Options (Right to Buy) | 2022-05-27 | A | A | 4,036 | $244.41 | 4,036 | D | $244.41 · 2023-05-27 to 2032-05-27 | 4,036 Common Stock | (F2) Stock Options vest as follows: 1,009 on May 27, 2023, 1,009 on May 27, 2024, 1,009 on May 27, 2025 and 1,009 on May 27, 2026. |